A Phase II, Single Arm, Multicenter Open Label Trial to Determine the Efficacy and Safety of Tisagenlecleucel (CTL019) in Adult Patients With Refractory or Relapsed Follicular Lymphoma

This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.

本研究为一项多中心II期临床试验，旨在评估替沙基仑赛（tisagenlecleucel）治疗复发或难治性滤泡性淋巴瘤（Follicular Lymphoma, FL）成人患者的有效性与安全性。